ClinicalTrials.Veeva

Menu

Male Reproduction COVID Sequelae Study (MARCOS).

University of Miami logo

University of Miami

Status

Withdrawn

Conditions

Infertility, Male

Study type

Observational

Funder types

Other

Identifiers

NCT04665258
20201451

Details and patient eligibility

About

The purpose of this study is to investigate the effects of COVID-19 Vaccination on semen parameters and to determine how long these possible changes may last following vaccination.

Sex

Male

Ages

18 to 50 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  1. Receiving COVID-19 vaccines
  2. Male age 18-50 years old

Exclusion criteria

  1. Adults unable to consent
  2. Women
  3. Prisoners
  4. Men who have been receiving Testosterone replacement therapy or anabolic steroids within the last year
  5. Men with a history of Azoospermia
  6. Men with a genetic or other medical condition known to be associated with decreased semen parameters (i.e. Klinefelter's syndrome, Y-Chromosome Microdeletion (YCMD), post-chemotherapy treatment, etc.)
  7. Positive COVID-19 test within the last 3 weeks

Trial design

0 participants in 1 patient group

COVID-19 vaccine group
Description:
Participants scheduled to receive the COVID-19 vaccine will be evaluated on its effect on semen parameters for up to 6 months post vaccination.

Trial contacts and locations

1

Loading...

Central trial contact

Manuel Molina, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems